Man dies of asthma attack after inhaler cost skyrockets to more than $500
United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...
Banking tech startup Zeta raises $50 million in fresh funding; valuation rises to $2 billion
The SoftBank-backed banking tech startup will be valued at $2 billion after this investment, up from around $1.45 billion ...
inc421h
Zeta’s Valuation Jumps To $2 Bn After Funding From Optum
Banking tech unicorn Zeta has secured $50 Mn (INR 434.3 Cr) in a fresh funding round from Optum at a valuation of $2 Bn ...
inc423h
Zeta Nets $50 Mn From Optum, Valuation Jumps To $2Bn
Banking tech unicorn Zeta has secured $50 Mn (INR 434.3 Cr) in a fresh funding round from Optum at a valuation of $2 Bn ...
Fintech unicorn Zeta secures $50 million at a valuation of $2 billion
This marks a significant jump from its pre-money valuation of $1.15 billion when it secured $250 million from SoftBank Vision ...
Government Executive9h
Protecting taxpayer dollars
The Government spends more than $1 trillion on healthcare every year through large programs such as Medicare, Medicaid, ...
UnitedHealth rebuts Justice Department allegations in $3.3B Amedisys deal
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...
centerforbiosimilars11h
Welcome Wezlana: Using Adalimumab to Predict Ustekinumab Market Potential
Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...